290 related articles for article (PubMed ID: 20177652)
1. [Primary and secondary prevention of skin cancer in organ transplant recipients].
Lonsdorf AS; Becker MR; Stockfleth E; Schäkel K; Ulrich C
Hautarzt; 2010 Mar; 61(3):195-206. PubMed ID: 20177652
[TBL] [Abstract][Full Text] [Related]
2. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
3. Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients.
Bangash HK; Colegio OR
Curr Treat Options Oncol; 2012 Sep; 13(3):354-76. PubMed ID: 22592596
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
[TBL] [Abstract][Full Text] [Related]
5. Skin cancer in organ transplant recipients--where do we stand today?
Ulrich C; Kanitakis J; Stockfleth E; Euvrard S
Am J Transplant; 2008 Nov; 8(11):2192-8. PubMed ID: 18782290
[TBL] [Abstract][Full Text] [Related]
6. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
Kovach BT; Sams HH; Stasko T
Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
[TBL] [Abstract][Full Text] [Related]
7. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment.
Stockfleth E; Ulrich C; Meyer T; Christophers E
Recent Results Cancer Res; 2002; 160():251-8. PubMed ID: 12079221
[TBL] [Abstract][Full Text] [Related]
8. Overview on non-melanoma skin cancers in solid organ transplant recipients.
Forchetti G; Suppa M; Del Marmol V
G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
[TBL] [Abstract][Full Text] [Related]
9. [Skin cancer in organ transplant patients. Epidemiology and management].
Leiter U; Garbe C
Hautarzt; 2010 Mar; 61(3):207-13. PubMed ID: 20145902
[TBL] [Abstract][Full Text] [Related]
10. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients.
Bakker D; Bakker WJ; Bekkenk MW; Luiten RM
Cells; 2023 Oct; 12(20):. PubMed ID: 37887285
[TBL] [Abstract][Full Text] [Related]
11. [Immunosuppressive therapy after transplantation. Dermatologic relevance and pathomechanisms].
Hofbauer G
Hautarzt; 2010 Mar; 61(3):214-9. PubMed ID: 20145903
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte cancer and its precursors in organ transplant patients.
Jenni D; Hofbauer GF
Curr Probl Dermatol; 2015; 46():49-57. PubMed ID: 25561206
[TBL] [Abstract][Full Text] [Related]
13. Skin changes following organ transplantation: an interdisciplinary challenge.
Ulrich C; Arnold R; Frei U; Hetzer R; Neuhaus P; Stockfleth E
Dtsch Arztebl Int; 2014 Mar; 111(11):188-94. PubMed ID: 24698074
[TBL] [Abstract][Full Text] [Related]
14. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
16. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
17. Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.
Herold M; Good AJ; Nielson CB; Longo MI
Dermatol Surg; 2019 Dec; 45(12):1442-1449. PubMed ID: 31403546
[TBL] [Abstract][Full Text] [Related]
18. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
[TBL] [Abstract][Full Text] [Related]
19. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
Tessari G; Girolomoni G
Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
[TBL] [Abstract][Full Text] [Related]
20. [Organ transplant recipients need intensive control and treatment of skin cancer].
Togsverd-Bo K; Sørensen SS; Hædersdal M
Ugeskr Laeger; 2013 May; 175(20):1408-11. PubMed ID: 23663395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
